Brad Wynja

Serving as VP of Business Development, Brad brings 20+ years of extensive and diverse life sciences industry experience to the leadership team at INCOG BioPharma. Prior to joining, Brad served as the Chief Financial Officer at Exelead, where he led the finance, business development, supply chain, project management, and IT organizations. Brad directed the acquisition of Exelead by Merk KGaA and its U.S. subsidiary MiliporeSigma in 2022. Prior to that, he held senior leadership roles in finance at Catalent and Covance/LabCorp.

Brad holds an MBA from Drake University, and he completed his undergraduate work in Accounting and Finance at the Central University of Iowa. He is also a member of the American Institute of Certified Public Accountants.